Affiliation:
1. Yan’an Hospital Affiliated to Kunming Medical University
Abstract
Abstract
CAR-T targeting CD19 have achieved significant effects in the treatment of B-line leukemia and lymphoma. However, the treated patients frequently relapsed and could not achieve complete remission. Therefore, improving the proliferation and cytotoxicity of CAR-T cells, reducing exhaustion and enhancing infiltration capacity are still issues to be solved. The IL-7 has been shown to enhance the memory characteristics of CAR-T cells, but the specific mechanism has yet to be elaborated. miRNAs play an important role in T cell activity. However, whether miRNA is involved in the activation of CAR-T cells by IL-7 has not yet been reported. Our previous study had established the 3rd generation CAR-T cells. The present study further found that IL-7 significantly increased the proliferation of anti-CD19 CAR-T cells, the ratio of CD4 + CAR + cells and the S phase of cell cycle. In vivo study showed that IL-7-stimulated CAR-T possessed stronger tumoricidal efficiency. Further we validated that IL-7 induced CAR-T cells had low expression of CDKN1A and high expression of miRNA-98-5p. Additionally, CDKN1A was associated with miRNA-98-5p. Our results, for the first time, suggested IL-7 could conspicuously enhance the proliferation of CAR-T cells through miRNA-98-5p targeting CDKN1A expression, which should be applied to CAR-T production.
Publisher
Research Square Platform LLC
Reference48 articles.
1. Clinical lessons learned from the first leg of the CAR T cell journey;Majzner RG;Nature medicine,2019
2. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude SL;The New England journal of medicine,2014
3. Clinical development of CAR T cell therapy in China: 2020 update;Wei J;Cellular & molecular immunology,2021
4. Evaluation of piggyBac-mediated anti-CD19 CAR-T cells after ex vivo expansion with aAPCs or magnetic beads;Yang LR;Journal of cellular and molecular medicine,2020
5. IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors in vivo;Koneru M;Oncoimmunology,2015